© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
FDA Approves First-in-Class Schizophrenia Drug: Daily Dose
October 07, 2024
Your daily dose of the clinical news you may have missed.
US Colorectal Cancer Screening Increased Three-Fold among Adults Aged 45-49 Years, but Disparities Persist
October 04, 2024
Increases in CRC screening were higher in high socioeconomic status and metropolitan areas, according to a new large cohort study.
Switching from HRT to Non-HRT: Safety Considerations for Menopausal Women
October 04, 2024
An expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.
Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: Daily Dose
October 03, 2024
Your daily dose of the clinical news you may have missed.
Youth with Chronic Pain Face Greater Symptoms of Depression, Anxiety than Pain-Free Peers
October 02, 2024
Findings from a systematic review and meta-analysis showed 1 in 3 youth with chronic pain were diagnosed with anxiety and 1 in 8 were diagnosed with depression.
Mental Health Conditions Common in Primary Care Settings: Daily Dose
October 02, 2024
Your daily dose of the clinical news you may have missed.
Non-Hormonal Therapy for Menopausal VMS: How Does Elinzanetant Differ from HRT?
October 01, 2024
JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program evaluating elinzanetant for menopausal VMS, discusses how non-hormonal therapy differs from HRT.
Novel Oral Antiobesity Drug Reduces Body Weight by up to 13%: Daily Dose
October 01, 2024
Your daily dose of the clinical news you may have missed.
FDA Approves First Self-Administered Flu Vaccine: Daily Dose
September 30, 2024
Your daily dose of the clinical news you may have missed.
Menopausal Hormone Therapy Use Declined in Past 2 Decades among Women Regardless of Age, Race/Ethnicity
September 27, 2024
Use of menopausal hormone therapy decreased from nearly 27% to 5% among postmenopausal women between 1999 and 2020, according to new research.